Pelizaeus–Merzbacher disease, recessive, acute infantile
Pelizaeus-Merzbacher Disease, Recessive, Acute Infantile (PMRD) is a rare genetic disorder that affects the central nervous system. It is a subtype of Pelizaeus-Merzbacher Disease (PMD), which is characterized by the disruption of myelin, the protective covering of nerve fibers in the brain. The recessive, acute infantile form of PMD is particularly severe and progresses rapidly.
Symptoms[edit | edit source]
The symptoms of Pelizaeus-Merzbacher Disease, Recessive, Acute Infantile, typically manifest within the first few months of life. These symptoms may include:
- Nystagmus - involuntary eye movements
- Hypotonia - reduced muscle tone
- Motor skill delays
- Cognitive impairment
- Seizures
As the disease progresses, affected individuals may experience severe neurological deterioration, leading to significant physical and intellectual disabilities.
Causes[edit | edit source]
Pelizaeus-Merzbacher Disease, Recessive, Acute Infantile, is caused by mutations in the PLP1 gene. This gene is crucial for the normal formation of myelin. In the recessive form of PMD, both copies of the PLP1 gene (one inherited from each parent) must be altered for a child to be affected. This differs from the more common X-linked form of PMD, where a single mutation in the PLP1 gene on the X chromosome can cause the disease.
Diagnosis[edit | edit source]
Diagnosis of Pelizaeus-Merzbacher Disease, Recessive, Acute Infantile, is based on clinical evaluation, Magnetic Resonance Imaging (MRI) of the brain, and genetic testing. MRI findings typically show evidence of delayed or abnormal myelination. Genetic testing can confirm the presence of mutations in the PLP1 gene.
Treatment[edit | edit source]
There is no cure for Pelizaeus-Merzbacher Disease, Recessive, Acute Infantile. Treatment focuses on managing symptoms and improving the quality of life for affected individuals. This may include:
- Physical therapy to improve motor skills
- Medications to control seizures
- Nutritional support
- Supportive care for respiratory problems
Prognosis[edit | edit source]
The prognosis for individuals with Pelizaeus-Merzbacher Disease, Recessive, Acute Infantile, is generally poor due to the rapid progression of the disease. Most affected children experience significant developmental delays and may have a shortened lifespan.
Research[edit | edit source]
Research efforts are ongoing to better understand Pelizaeus-Merzbacher Disease and to find effective treatments. These include studies on gene therapy, which aims to correct the underlying genetic mutations, and therapies to promote myelin repair.
Pelizaeus–Merzbacher disease, recessive, acute infantile Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD